Many of Son's past tweets are company-focused although it was not his first time to touch on societal issues. In 2014, he tweeted a video o...

In March this year, Biocon received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine.

Biocon has received approval from the Japanese health authority to sell its biosimilar product 'Insulin Glargine' in that country.

Japan's health ministry has officially notified the MRL for ethoxyquin in shrimps. It has been fixed at 0.2 ppm in crustaceans including fa...

Pharma major Ranbaxy said it has launched hypertension drug Amlodipine tablets in Japan.